FDA cleared the Optiflow Switch+ Filtered Nasal Interface with CO2 Sampling (AA042J) from Fisher & Paykel Healthcare, Ltd. on Dec 19, 2025 under K253479, a special 510(k). The device falls under product code BTT, Humidifier, Respiratory Gas, (Direct Patient Interface), regulated at 21 CFR 868.5450 as a Class 2 device. The review panel was Anesthesiology.
FDA logged the submission as received on Oct 14, 2025. The decision came 66 days later, inside the 90 FDA-day goal for a 510(k).
Fisher & Paykel Healthcare, Ltd. has one other decision in the tracker over the last 12 months: K250651 (OptiPAP Junior Flexi Tube US (OPTIPAPFUS); OptiPAP Junior Nasal Prongs XXS (OPTIPAPPXXS); OptiPAP Junior Nasal Prongs XS (OPTIPAPPXS); OptiPAP Junior Nasal Prongs S (OPTIPAPPS); OptiPAP Junior Nasal Prongs M (OPTIPAPPM); OptiPAP Junior Nasal Prongs L (OPTIPAPPL); OptiPAP Junior Nasal Prongs XL (OPTIPAPPXL); OptiPAP Junior Nasal Mask XXS (OPTIPAPMXXS); OptiPAP Junior Nasal Mask XS (OPTIPAPMXS); OptiPAP Junior Nasal Mask S (OPTIPAPMS); OptiPAP Junior Nasal Mask M (OPTIPAPMM); OptiPAP Jun).